Astrana Health Management

Management Kriterienprüfungen 2/4

Astrana Health's CEO ist Brandon Sim , ernannt in Jan 2024, hat eine Amtszeit von weniger als einem Jahr. Die jährliche Gesamtvergütung beträgt $14.31M , bestehend aus 5% Gehalt und 95% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 3.09% der Aktien des Unternehmens, im Wert von $73.13M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 1.1 Jahre bzw. 5.6 Jahre.

Wichtige Informationen

Brandon Sim

Geschäftsführender

US$14.3m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts5.0%
Amtszeit als Geschäftsführerless than a year
Eigentum des Geschäftsführers3.1%
Durchschnittliche Amtszeit des Managements1.2yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder5.7yrs

Jüngste Management Updates

Recent updates

Is Astrana Health, Inc. (NASDAQ:ASTH) Trading At A 21% Discount?

Sep 26
Is Astrana Health, Inc. (NASDAQ:ASTH) Trading At A 21% Discount?

Astrana Health's (NASDAQ:ASTH) Returns On Capital Not Reflecting Well On The Business

Sep 12
Astrana Health's (NASDAQ:ASTH) Returns On Capital Not Reflecting Well On The Business

Is Astrana Health (NASDAQ:ASTH) Using Too Much Debt?

Aug 28
Is Astrana Health (NASDAQ:ASTH) Using Too Much Debt?

Astrana Health, Inc.'s (NASDAQ:ASTH) 29% Jump Shows Its Popularity With Investors

Aug 02
Astrana Health, Inc.'s (NASDAQ:ASTH) 29% Jump Shows Its Popularity With Investors

Is There Now An Opportunity In Astrana Health, Inc. (NASDAQ:ASTH)?

Jun 19
Is There Now An Opportunity In Astrana Health, Inc. (NASDAQ:ASTH)?

Capital Allocation Trends At Astrana Health (NASDAQ:ASTH) Aren't Ideal

Jun 02
Capital Allocation Trends At Astrana Health (NASDAQ:ASTH) Aren't Ideal

Astrana Health, Inc. (NASDAQ:ASTH) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

May 09
Astrana Health, Inc. (NASDAQ:ASTH) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Investors Still Waiting For A Pull Back In Astrana Health, Inc. (NASDAQ:ASTH)

Apr 15
Investors Still Waiting For A Pull Back In Astrana Health, Inc. (NASDAQ:ASTH)

At US$40.82, Is Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Worth Looking At Closely?

Feb 25
At US$40.82, Is Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Worth Looking At Closely?

Is Apollo Medical Holdings (NASDAQ:AMEH) Using Too Much Debt?

Feb 07
Is Apollo Medical Holdings (NASDAQ:AMEH) Using Too Much Debt?

Apollo Medical Holdings: Good Company, Not Quite A Hold

Jan 17

With Apollo Medical Holdings, Inc. (NASDAQ:AMEH) It Looks Like You'll Get What You Pay For

Dec 27
With Apollo Medical Holdings, Inc. (NASDAQ:AMEH) It Looks Like You'll Get What You Pay For

Returns On Capital At Apollo Medical Holdings (NASDAQ:AMEH) Have Stalled

Nov 08
Returns On Capital At Apollo Medical Holdings (NASDAQ:AMEH) Have Stalled

Should You Investigate Apollo Medical Holdings, Inc. (NASDAQ:AMEH) At US$30.62?

Oct 26
Should You Investigate Apollo Medical Holdings, Inc. (NASDAQ:AMEH) At US$30.62?

Apollo Medical Holdings (NASDAQ:AMEH) Has A Pretty Healthy Balance Sheet

Sep 22
Apollo Medical Holdings (NASDAQ:AMEH) Has A Pretty Healthy Balance Sheet

Returns At Apollo Medical Holdings (NASDAQ:AMEH) Appear To Be Weighed Down

Aug 04
Returns At Apollo Medical Holdings (NASDAQ:AMEH) Appear To Be Weighed Down

A Look At The Intrinsic Value Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH)

Jul 19
A Look At The Intrinsic Value Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH)

We Think Apollo Medical Holdings (NASDAQ:AMEH) Can Stay On Top Of Its Debt

Jun 19
We Think Apollo Medical Holdings (NASDAQ:AMEH) Can Stay On Top Of Its Debt

Apollo Medical Holdings' (NASDAQ:AMEH) Returns On Capital Are Heading Higher

May 05
Apollo Medical Holdings' (NASDAQ:AMEH) Returns On Capital Are Heading Higher

Does This Valuation Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Imply Investors Are Overpaying?

Apr 20
Does This Valuation Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Imply Investors Are Overpaying?

Is Apollo Medical Holdings (NASDAQ:AMEH) A Risky Investment?

Mar 21
Is Apollo Medical Holdings (NASDAQ:AMEH) A Risky Investment?

Apollo Medical Holdings (NASDAQ:AMEH) Has More To Do To Multiply In Value Going Forward

Jan 06
Apollo Medical Holdings (NASDAQ:AMEH) Has More To Do To Multiply In Value Going Forward

Is Apollo Medical Holdings (NASDAQ:AMEH) Using Too Much Debt?

Dec 16
Is Apollo Medical Holdings (NASDAQ:AMEH) Using Too Much Debt?

Apollo Medical to acquire Valley Oaks Medical Group

Oct 05

Apollo Medical to acquire a San Francisco Bay area physicians' group, health plan

Sep 26

A Look At The Fair Value Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH)

Sep 21
A Look At The Fair Value Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH)

The Return Trends At Apollo Medical Holdings (NASDAQ:AMEH) Look Promising

Sep 06
The Return Trends At Apollo Medical Holdings (NASDAQ:AMEH) Look Promising

With EPS Growth And More, Apollo Medical Holdings (NASDAQ:AMEH) Makes An Interesting Case

Aug 22
With EPS Growth And More, Apollo Medical Holdings (NASDAQ:AMEH) Makes An Interesting Case

Apollo Medical Q2 GAAP EPS beats estimate, co reiterates FY 2022 revenue guidance

Aug 04

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Brandon Sim im Vergleich zu den Einnahmen von Astrana Health verändert?
DatumGesamtvergütungGehaltUnternehmensgewinne
Jun 30 2024n/an/a

US$68m

Mar 31 2024n/an/a

US$62m

Dec 31 2023US$14mUS$712k

US$61m

Sep 30 2023n/an/a

US$45m

Jun 30 2023n/an/a

US$46m

Mar 31 2023n/an/a

US$45m

Dec 31 2022US$15mUS$670k

US$45m

Sep 30 2022n/an/a

US$58m

Jun 30 2022n/an/a

US$69m

Mar 31 2022n/an/a

US$70m

Dec 31 2021US$9mUS$364k

US$69m

Sep 30 2021n/an/a

US$70m

Jun 30 2021n/an/a

US$53m

Mar 31 2021n/an/a

US$47m

Dec 31 2020US$1mUS$124k

US$38m

Sep 30 2020n/an/a

US$35m

Jun 30 2020n/an/a

US$22m

Mar 31 2020n/an/a

US$18m

Dec 31 2019US$73kUS$24k

US$14m

Vergütung im Vergleich zum Markt: BrandonDie Gesamtvergütung ($USD14.31M) liegt über dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt US ($USD5.62M).

Entschädigung vs. Einkommen: BrandonDie Vergütung des Vorstandsvorsitzenden entsprach im vergangenen Jahr der Unternehmensleistung.


Geschäftsführer

Brandon Sim (30 yo)

less than a year

Amtszeit

US$14,311,250

Vergütung

Mr. Brandon K. Sim, MS, is President and Chief Executive Officer at Astrana Health, Inc. (formerly known as Apollo Medical Holdings, Inc.) since January 19, 2024 and had been its Co-Chief Executive Officer...


Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Kenneth Sim
Co-Founder & Executive Chairman6.8yrsUS$5.22m2.4%
$ 66.1m
Brandon Sim
President & CEOless than a yearUS$14.31m3.09%
$ 85.2m
Thomas Lam
Co-Founder & Vice Chairmanless than a yearUS$5.22m3.07%
$ 84.6m
Chandan Basho
CFO, COO & Corporate Secretary2.3yrsUS$5.70m0.31%
$ 8.5m
WaiChow Young
Senior Vice President of Health Affairsless than a yearUS$562.77k2.41%
$ 66.6m
John Vong
Chief Accounting Officer2.2yrskeine Daten0.037%
$ 1.0m
Rita Pew
Vice President of People & Operationsno datakeine Datenkeine Daten
Jeremy Jackson
Chief Quality Officer3.5yrskeine Datenkeine Daten
Neil Ahuja
President of Provider Solutions2.7yrskeine Datenkeine Daten
Carlos Palacios
Chief Medical Officer for Texas1.2yrskeine Datenkeine Daten
Dinesh Kumar
Chief Medical Officerless than a yearkeine Daten0.30%
$ 8.4m
Shawn Arnone
Managing Director of the Capital Markets Groupless than a yearkeine Datenkeine Daten

1.2yrs

Durchschnittliche Betriebszugehörigkeit

55yo

Durchschnittliches Alter

Erfahrenes Management: ASTHDas Führungsteam des Unternehmens gilt nicht als erfahren ( 1.1 Jahre durchschnittliche Betriebszugehörigkeit), was auf ein neues Team schließen lässt.


Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Kenneth Sim
Co-Founder & Executive Chairman6.8yrsUS$5.22m2.4%
$ 66.1m
Thomas Lam
Co-Founder & Vice Chairmanless than a yearUS$5.22m3.07%
$ 84.6m
Weili Dai
Independent Director2.8yrsUS$211.95k0.015%
$ 405.4k
Mitchell Kitayama
Lead Independent Director6.8yrsUS$374.01k0.036%
$ 999.7k
David Schmidt
Independent Director11.3yrsUS$329.87k0.019%
$ 523.4k
John Chiang
Independent Director5.7yrsUS$273.71k0.032%
$ 890.5k
Matthew Mazdyasni
Director5yrsUS$274.13k0.017%
$ 467.2k
Linda Marsh
Director5.7yrsUS$211.95k0.16%
$ 4.3m
J. Estradas
Independent Director2.8yrskeine Datenkeine Daten

5.7yrs

Durchschnittliche Betriebszugehörigkeit

70yo

Durchschnittliches Alter

Erfahrener Vorstand: ASTHDie Vorstandsmitglieder gelten als erfahren (5.6 Jahre durchschnittliche Amtszeit).